|
1
|
Feng J, Funk WD, Wang SS, Weinrich SL,
Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, et al:
The RNA component of human telomerase. Science. 269:1236–1241.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cukusić A, Skrobot Vidacek N, Sopta M and
Rubelj I: Telomerase regulation at the crossroads of cell fate.
Cytogenet Genome Res. 122:263–272. 2008. View Article : Google Scholar
|
|
4
|
Poole JC, Andrews LG and Tollefsbol TO:
Activity, function, and gene regulation of the catalytic subunit of
telomerase (hTERT). Gene. 269:1–12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Chen X, Xu X, Wang X, Wang X,
Yuan G, Sun D, Ka W, He D, Wen Z, et al: Knockdown of hTERT alters
biophysical properties of K562 cells resulting in decreased
migration rate in vitro. Cell Biochem Biophys. 61:595–603. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bertorelle R, Briarava M, Rampazzo E,
Biasini L, Agostini M, Maretto I, Lonardi S, Friso ML, Mescoli C,
Zagonel V, et al: Telomerase is an independent prognostic marker of
overall survival in patients with colorectal cancer. Br J Cancer.
108:278–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Daniel M, Peek GW and Tollefsbol TO:
Regulation of the human catalytic subunit of telomerase (hTERT).
Gene. 498:135–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schetter AJ, Okayama H and Harris CC: The
role of microRNAs in colorectal cancer. Cancer J. 18:244–252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen L, Lü MH, Zhang D, Hao NB, Fan YH, Wu
YY, Wang SM, Xie R, Fang DC, Zhang H, et al: miR-1207-5p and
miR-1266 suppress gastric cancer growth and invasion by targeting
telomerase reverse transcriptase. Cell Death Dis. 5:e10342014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mitomo S, Maesawa C, Ogasawara S, Iwaya T,
Shibazaki M, Yashima-Abo A, Kotani K, Oikawa H, Sakurai E, Izutsu
N, et al: Downregulation of miR-138 is associated with
overexpression of human telomerase reverse transcriptase protein in
human anaplastic thyroid carcinoma cell lines. Cancer Sci.
99:280–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ritchie ME, Silver J, Oshlack A, Holmes M,
Diyagama D, Holloway A and Smyth GK: A comparison of background
correction methods for two-colour microarrays. Bioinformatics.
23:2700–2707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kayala MA and Baldi P: Cyber-T web server:
differential analysis of high-throughput data. Nucleic Acids Res.
40(W1): W553–W559. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baldi P and Long AD: A Bayesian framework
for the analysis of microarray expression data: regularized t-test
and statistical inferences of gene changes. Bioinformatics.
17:509–519. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dweep H, Gretz N and Sticht C: miRWalk
database for miRNA-target interactions. Methods Mol Biol.
1182:289–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Li J, Cao X, Fang Y, Liao ZE, Liu YY,
Huang BD and Han YJ: Overexpression of hTERT in potentially
malignant colorectal laterally spreading tumors. Mol Med Rep.
7:1409–1412. 2013.PubMed/NCBI
|
|
20
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang YY, Sun G, Luo H, Wang XF, Lan FM,
Yue X, Fu LS, Pu PY, Kang CS, Liu N, et al: miR-21 modulates hTERT
through a STAT3-dependent manner on glioblastoma cell growth. CNS
Neurosci Ther. 18:722–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chi SW, Zang JB, Mele A and Darnell RB:
Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature.
460:479–486. 2009.PubMed/NCBI
|
|
23
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Q, Tang H, Yin S and Dong C:
Downregulation of microRNA-138 enhances the proliferation,
migration and invasion of cholangiocarcinoma cells through the
upregulation of RhoC/p-ERK/MMP-2/MMP-9. Oncol Rep. 29:2046–2052.
2013.PubMed/NCBI
|
|
25
|
Long L, Huang G, Zhu H, Guo Y, Liu Y and
Huo J: Down-regulation of miR-138 promotes colorectal cancer
metastasis via directly targeting TWIST2. J Transl Med. 11:2752013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Faltejskova P, Svoboda M, Srutova K,
Mlcochova J, Besse A, Nekvindova J, Radova L, Fabian P, Slaba K,
Kiss I, et al: Identification and functional screening of microRNAs
highly deregulated in colorectal cancer. J Cell Mol Med.
16:2655–2666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gougelet A, Pissaloux D, Besse A, Perez J,
Duc A, Dutour A, Blay JY and Alberti L: Micro-RNA profiles in
osteosarcoma as a predictive tool for ifosfamide response. Int J
Cancer. 129:680–690. 2011. View Article : Google Scholar
|
